Breast Imaging Devices Market Outlook Signals Expansion To $7.24 Billion Through 2030

The breast imaging devices market is poised for significant growth as advancements in technology and increasing demand for early cancer detection continue to shape the industry. With innovations focused on improving diagnostic precision and patient outcomes, this sector is attracting considerable attention from healthcare providers and technology developers alike.

Projected Growth and Market Size of Breast Imaging Devices
The breast imaging devices market is forecasted to expand substantially, reaching a valuation of $7.24 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.7%. Factors driving this upward trend include rising investments in artificial intelligence (AI)-enabled diagnostic tools, a growing emphasis on early breast cancer detection, expansion in outpatient imaging services, and advancements in non-ionizing imaging technologies. Additionally, the market is witnessing increased demand for personalized breast care solutions and the integration of cutting-edge imaging systems.

Download a free sample of the breast imaging devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3291&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Factors Fueling Growth in the Breast Imaging Devices Market
Investment in AI-powered diagnostic solutions is playing a crucial role in accelerating market expansion. These technologies enhance the accuracy and efficiency of breast cancer screening, enabling earlier and more precise detection.
Another significant driver is the rising adoption of non-ionizing imaging systems, which offer safer alternatives to traditional methods. The focus on minimally invasive diagnostic techniques and the growth of outpatient imaging centers are also contributing to the market's steady progress.

Leading Companies Dominating the Breast Imaging Devices Industry
Prominent players in this market include Siemens Healthineers AG, Hologic Inc, GE Healthcare, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V, Aurora Imaging Technology Inc, Delphinus Medical Technologies Inc, Micrima Limited, SonoCiné Inc, Planmed Oy, Carestream Health Inc, Dilon Technologies Inc, Toshiba Medical Systems Corporation, SuperSonic Imagine SA, IMS Giotto (Giotto Imaging), Samsung Medison Co Ltd, Hitachi Ltd, Koning Corporation, Metaltronica S.p.A, CMT Medical Technologies Ltd, Gamma Medica Inc, and KUB Technologies Inc.
In a recent development from May 2024, South Korea-based AI cancer diagnostics firm Lunit acquired New Zealand's Volpara Health Technologies Limited. This move is aimed at strengthening Lunit's AI-driven cancer screening capabilities, expanding its presence in the U.S. market, and fostering innovation in early breast cancer detection.

View the full breast imaging devices market report:
https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends and Technological Advances in the Breast Imaging Devices Market
Industry leaders are prioritizing the development of sophisticated imaging techniques to boost early detection rates and enhance diagnostic accuracy. These advanced methods include digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI), which provide more detailed and precise visualization of breast tissue.
For example, in October 2024, StoneSprings Hospital Centre in the U.S. introduced cutting-edge breast imaging technology that incorporates digital mammography and 3D tomosynthesis. This system integrates AI algorithms to support radiologists by highlighting potential concerns, thereby reducing missed diagnoses and improving overall image interpretation.

Breakdown of Breast Imaging Devices Market Segments
The breast imaging devices market is categorized by product type, technology, and end user:
1) Product Types include Tomosynthesis, Breast Ultrasound, Breast Magnetic Resonance Imaging (MRI), Mammography, Nuclear Imaging, and Other Product Types.
2) Technologies are classified as Ionizing and Non-Ionizing.
3) End Users consist of Hospitals and Clinics, Breast Care Centers, and Diagnostic Imaging Centers.

Further subcategories detail specific product types:
- Tomosynthesis includes Digital Breast Tomosynthesis (DBT) and 3D Mammography Systems.
- Breast Ultrasound covers Handheld Ultrasound, Automated Breast Ultrasound System (ABUS), and Elastography.
- Breast MRI is divided into Contrast-Enhanced MRI and Functional MRI.
- Mammography consists of Digital Mammography, Film Mammography, and 2D Mammography.
- Nuclear Imaging comprises Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).
- Other Products include Infrared Imaging, Molecular Imaging Systems, and Stereotactic Breast Biopsy Devices.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.